Phase 2 trial results of DN24-02, a HER2-targeted autologous cellular immunotherapy in HER2+ urothelial cancer patients (pts) Meeting Abstract
| Authors: | Bajorin, D. F.; Sharma, P.; Quinn, D. I.; Plimack, E. R.; Hoffman-Censits, J. H.; O'Donnell, P. H.; Siefker-Radtke, A. O.; Sheikh, N. A.; Lill, J. S.; Trager, J. B.; Gomella, L. G. |
| Abstract Title: | Phase 2 trial results of DN24-02, a HER2-targeted autologous cellular immunotherapy in HER2+ urothelial cancer patients (pts) |
| Meeting Title: | 52nd Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 34 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2016 Jun 3-7 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2016-05-20 |
| Start Page: | 247s |
| Language: | English |
| ACCESSION: | WOS:000404665407086 |
| DOI: | 10.1200/JCO.2016.34.15_suppl.4513 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 4513 -- Source: Wos |
